The following products and technologies are currently open for partnership evaluation with a strategic partner:
Vyome’s MRTTM approach focuses on the development of effective, targeted and safe topical therapeutics against fungal and bacterial infections of the skin, with better pharmacological profiles than the incumbent therapies. This promising MRTTM intends to reduce dosages and application frequencies of topical formulations, achieve faster onset of action and amplify relief for the patient.
Currently, Vyome is open for various partnership opportunities for the Molecular Replacement Therapeutics Platform technology, and for its clinically tested products. For more details, please write to us: email@example.com
As a therapeutic area, the anti-fungal space has suffered from a lack of innovation for decades. Doctors & patients are dissatisfied with the current treatment options and there are multiple unmet needs. Vyome's anti-fungal platform technology for treatment of recalcitrant fungal infections has aided in development of novel anti-fungal products with enhanced efficacy over existing leading brands, as envisaged in the in vitro & in vivo studies performed by Vyome. Vyome has developed treatment options for Tinea & Candida fungi species.
For partnership queries, write to: firstname.lastname@example.org
Copyright © 2015 Vyome Therapeutics Inc. All rights reserved.